Combination of calcium channel blockers and BRAF and / or MEK inhibitors to treat melanoma

FR3167846A1Pending Publication Date: 2026-05-01UNIV DE POITIERS +4

-1 Cites 0 Cited by

Patent Information

Authority / Receiving Office: FR · FR
Patent Type: Applications
Current Assignee / Owner: UNIV DE POITIERS
Filing Date: 2024-10-30
Publication Date: 2026-05-01

Application Information

Patent Timeline

30 Oct 2024

Application

01 May 2026

Publication

FR3167846A1

IPC: A61K31/13; A61K31/135; A61K31/137; A61P35/00

CPC: A61K31/4422; A61K31/277; A61K31/437; A61K31/506; A61K31/4523; A61K31/4184; A61K31/519; A61K45/06

Inventors: PENNA AUBIN; GIRARD CHRISTOPHE

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Abstract

The invention relates to the use of a specific L-type calcium channel inhibitor (LTCC) in combination with a BRAF inhibitor (BRAFi) and / or a MEK inhibitor (MEKi) for the treatment of melanoma in a patient.

Need to check novelty before this filing date? Find Prior Art